Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clostridioides difficile is a Gram-positive, spore-forming, obligate anaerobic bacterium that is a major cause of antibiotic-associated diarrhea and colitis in humans. It produces toxins TcdA and TcdB, which disrupt host cell signaling and cause inflammation and cell death in the colon. Spores allow for environmental persistence and transmission, and antibiotic resistance is a growing concern.
N/A
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridioides difficile (C. difficile).